ENG and neoplasm: Concerning the recent identification of CD105 as a marker of pro-tumorigenic CAFs in PDAC [29], further research will be required to determine the best way to target the CD105-positive CAFs, thereby specifically depleting the pro-tumorigenic CAF subpopulation while still preserving the tumor-restraining one.